$11.7B
Reported book value
| # | Security | Shares | Share Δ QoQ | Value | % of book |
|---|---|---|---|---|---|
| 1 | MDGL Madrigal Pharmaceuticals Inc | 2.0M | +0.0% | $1.1B | 9.1% |
| 2 | ARGX Argenx Se | 709,446 | +0.0% | $658M | 5.6% |
| 3 | PTCT Ptc Therapeutics Inc | 7.7M | +0.0% | $632M | 5.4% |
| 4 | PTGX Protagonist Therapeutics Inc | 5.1M | +0.0% | $620M | 5.3% |
| 5 | CGON Cg Oncology Inc | 8.5M | +21.9% | $605M | 5.2% |
| 6 | INSM Insmed Inc | 4.8M | +0.0% | $516M | 4.4% |
| 7 | TNGX Tango Therapeutics Inc | 13.9M | +4.5% | $435M | 3.7% |
| 8 | SYRE Spyre Therapeutics Inc | 4.3M | +1.9% | $377M | 3.2% |
| 9 | CELC Celcuity Inc | 3.3M | +8.7% | $346M | 3.0% |
| 10 | ERAS Erasca Inc | 17.9M | +11.1% | $329M | 2.8% |
| 11 | RDNT Radnet Inc | 4.8M | +13.1% | $299M | 2.6% |
| 12 | ORKA Oruka Therapeutics Inc | 3.1M | +52.5% | $299M | 2.6% |
| 13 | NTRA Natera Inc | 1.0M | −20.0% | $271M | 2.3% |
| 14 | RARE Ultragenyx Pharmaceutical In | 7.8M | +113.7% | $260M | 2.2% |
| 15 | IRTC Irhythm Holdings Inc | 2.2M | +30.8% | $260M | 2.2% |
| 16 | CYTK Cytokinetics Inc | 2.9M | +5.2% | $244M | 2.1% |
| 17 | KLRA Kailera Therapeutics Inc | 10.8M | — | $237M | 2.0% |
| 18 | ESTA Establishment Labs Hldgs Inc | 2.7M | +0.0% | $228M | 1.9% |
| 19 | GH Guardant Health Inc | 1.5M | +0.0% | $222M | 1.9% |
| 20 | NBIX Neurocrine Biosciences Inc | 1.3M | +19.4% | $214M | 1.8% |
| 21 | TARS Tarsus Pharmaceuticals Inc | 3.4M | +0.3% | $211M | 1.8% |
| 22 | STOK Stoke Therapeutics Inc | 5.6M | +0.0% | $184M | 1.6% |
| 23 | UNIQURE NV Uniqure Nv | 3.9M | +52.4% | $182M | 1.5% |
| 24 | ACAD Acadia Pharmaceuticals Inc | 7.1M | +0.0% | $181M | 1.5% |
| 25 | RGEN Repligen Corp | 1.2M | +2.9% | $169M | 1.4% |
| 26 | URGN Urogen Pharma Ltd | 4.5M | +0.0% | $167M | 1.4% |
| 27 | GHRS Gh Research Plc | 5.9M | +0.0% | $160M | 1.4% |
| 28 | IMCR Immunocore Hldgs Plc | 4.9M | +0.0% | $155M | 1.3% |
| 29 | CMPS Compass Pathways Plc | 10.7M | +0.6% | $151M | 1.3% |
| 30 | IMTX Immatics N.V | 12.9M | +0.6% | $131M | 1.1% |
| 31 | ZLAB Zai Lab Ltd | 6.6M | +0.0% | $125M | 1.1% |
| 32 | IMVT Immunovant Inc | 3.2M | +0.0% | $122M | 1.0% |
| 33 | BLTE Belite Bio Inc | 715,332 | +0.0% | $110M | 0.9% |
| 34 | XNCR Xencor Inc | 6.8M | +0.0% | $109M | 0.9% |
| 35 | TSHA Taysha Gene Therapies Inc | 13.6M | −0.9% | $92M | 0.8% |
| 36 | COGT Cogent Biosciences Inc | 2.3M | −57.7% | $89M | 0.8% |
| 37 | ALKS Alkermes Plc | 1.7M | +0.0% | $88M | 0.7% |
| 38 | GPCR Structure Therapeutics Inc | 1.6M | — | $86M | 0.7% |
| 39 | REPL Replimune Group Inc | 7.4M | +0.7% | $82M | 0.7% |
| 40 | CSTL Castle Biosciences Inc | 2.8M | +0.7% | $66M | 0.6% |
| 41 | CADL Candel Therapeutics Inc | 6.4M | +0.0% | $66M | 0.6% |
| 42 | RCKT Rocket Pharmaceuticals Inc | 17.7M | +0.0% | $60M | 0.5% |
| 43 | KOD Kodiak Sciences Inc | 1.5M | +0.0% | $58M | 0.5% |
| 44 | AKTS Aktis Oncology Inc | 1.6M | +0.0% | $51M | 0.4% |
| 45 | AXGN Axogen Inc | 1.0M | — | $47M | 0.4% |
| 46 | DANAHER CORP DEL Danaher Corp Del | 230,000 | — | $44M | 0.4% |
| 47 | CGEM Cullinan Therapeutics Inc | 2.4M | +38.6% | $43M | 0.4% |
| 48 | NGNE Neurogene Inc | 1.4M | +0.0% | $43M | 0.4% |
| 49 | HNGE Hinge Health Inc | 500,000 | −74.1% | $42M | 0.4% |
| 50 | OBIO Orchestra Biomed Hldgs Inc | 9.6M | +15.0% | $41M | 0.4% |